# ClinicalTrials.gov record NCT00456885

> PeptideScanner retained ClinicalTrials.gov record NCT00456885 at 2026-07-30T21:23:14.762Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct00456885-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-09-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00456885-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00456885-exenatide-v1.json
- Content SHA-256: `99391bd7d70115455e4e9c11b7f4ac4ac808b4cb6f5510edadd454add7066e26`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00456885 ([`ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78`](#source-ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00456885 at 2026-07-30T21:23:14.762Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78`](#source-ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00456885 at 2026-07-30T21:23:14.762Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78`](#source-ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78`](#source-ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78))

## Sources

<a id="source-ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78"></a>
- **ClinicalTrials.gov record NCT00456885 · retained source version 2017-09-11:f9bcb3c24c781e59ac8d544a4c30204e78cd5a09a1a3a285ecb453d9034a460e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00456885) (`ctg-observation-nct00456885-2017-09-11-f9bcb3c24c78`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00456885." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00456885-exenatide-v1.json SHA-256: 99391bd7d70115455e4e9c11b7f4ac4ac808b4cb6f5510edadd454add7066e26.